bioRxiv Science⌕ Search

Biology subjects

Dastych, J.

Publications and source records attributed to Dastych, J..

2 recordsLinked to original sources

Combined Lytic Score as a new metric to quantify phage-host specificity, tested in a screening study on a collection of Salmonella strains.

Bacteriophages are promising alternatives for antibiotics. One challenge of developing bacteriophage-based preparation for practical application is to understand expected host range of such products. We evaluated the host range and lytic activity of BAFASAL(R), a four-phage cocktail targeting Salmonella in poultry production. For that purpose, we developed a new composite metric, the Combined Lytic Score (CLS), integrating results from two in vitro assays: serial dilutions spot test on semisolid medium and spectrophotometric growth inhibition in liquid culture. Using this approach phage cocktail was tested against collection of 72 Salmonella strains, including 55 S. Enteritidis isolates representing diverse geographic origins and genomic backgrounds. Spot test patterns were transformed into a continuous scale using the Most Probable Number (MPN) approach to estimate the number of phages required for visible lysis. In parallel, growth inhibition was quantified as the area-under-curve-based inhibition score (ANS). Both metrics were normalized and combined into CLS as a projection onto the regression line describing their correlation (R{superscript 2} {approx} 0.82). More than 65% of S. Enteritidis strains, reached normalized CLS values higher 75%, indicating high susceptibility to BAFASAL(R) in vitro. Phage susceptibility did not correlate with either phenotypic antibiotic resistance or the number of resistance and virulence genes. CLS provides a quantitative method to integrate different experimental methods of determination of bacterial susceptibility to bacteriophages and to rank bacterial strains by phage susceptibility. This approach supports robust host range determination and may facilitate regulatory evaluation and rational design of phage-based interventions in food safety and animal production. IMPORTANCEAssessment of bacteriophage host range is an important step in characterization of bacteriophage strains both in basic and translational research, yet it is still commonly based on qualitative or poorly standardized assays. This lack of harmonization limits reproducibility and complicates comparisons across studies, laboratories, and application contexts. In this work, we propose the Combined Lytic Score (CLS) as a quantitative framework that integrates outcomes from two widely used experimental approaches: serial-dilution spot assays and microtiter-based growth inhibition kinetics. By converting spot-test results into a continuous, concentration-dependent metric and combining them with normalized kinetic inhibition data, CLS enables more consistent interpretation of phage-host interaction outcomes. Application of CLS to a diverse collection of Salmonella enterica strains demonstrates how this approach can support systematic, scalable host range analyses. The CLS framework provides a practical step toward improved standardization of phage susceptibility testing, facilitating clearer data interpretation and comparison in both environmental and applied microbiology research.

microbiology↗

Examining the effects of an anti-Salmonella bacteriophage preparation, BAFASAL, on ex vivo human gut microbiome composition and function using a multi-omics approach

Salmonella infections (salmonellosis) pose serious health risks to humans, usually via contamination in our food chain. This foodborne pathogen causes major food losses and human illnesses that result in significant economic impacts. Pathogens such as Salmonella have traditionally been kept at bay through the use of antibiotics, but antibiotic overuse within the food industry has led to the development of numerous multidrug-resistant bacterial strains. Thus, governments are now restricting antibiotic use, forcing the industry to search for alternatives to secure safe food chains. Bacteriophages, viruses that infect and kill bacteria, are currently being investigated and used as replacement treatments and prophylactics due to their specificity and efficacy. They are generally regarded as safe alternatives to antibiotics as they are natural components of the ecosystem. One example is BAFASEL, a commercial bacteriophage mixture that specifically targets Salmonella and is currently approved for use in poultry farming. However, when specifically used in the industry they can also make their way into humans through our food chain or exposure as is the case for antibiotics. In particular, agricultural workers could be repeatedly exposed to bacteriophages supplemented in animal feeds. To the best of our knowledge, no studies have investigated the effects of such exposure to bacteriophages on the human gut microbiome. In this study, we used a novel in vitro assay called RapidAIM to investigate BAFASALs potential impact on five individual human gut microbiomes. Multi-omics analyses, including 16S rRNA gene sequencing and metaproteomic, revealed that ex vivo human gut microbiota composition and function were unaffected by BAFASAL treatment providing an additional measure for its safety. Due to the critical role of the gut microbiome in human health and the known role of bacteriophages in regulation of microbiome composition and function, we suggest assaying the impact of bacteriophage-cocktails on the human gut microbiome as a part of their safety assessment. Graphical Abstract O_FIG_DISPLAY_L [Figure 1] M_FIG_DISPLAY C_FIG_DISPLAY

microbiology↗